Aldose reductase inhibitor Epalrestat alleviates high glucose-induced cardiomyocyte apoptosis via ROS
- Type
- Retraction
- Notice date
- 11/15/2024 0:00
- Journal
- European Review for Medical and Pharmacological Sciences
- Publisher
- Verduci Editore
- Notice DOI
- 10.26355/eurrev_202411_36906
- Original paper DOI
- 10.26355/eurrev_201908_18660